Photo from wikipedia
Sprue-like enteropathy in association with olmesartan was first described in 2012. Several study results have since further supported the association between angiotensin II receptor blockers (ARBs) and sprue-like enteropathy, characterized… Click to show full abstract
Sprue-like enteropathy in association with olmesartan was first described in 2012. Several study results have since further supported the association between angiotensin II receptor blockers (ARBs) and sprue-like enteropathy, characterized by chronic diarrhea and weight loss in combination with villous atrophy that has been shown to improve after drug withdrawal across Western countries. Herein, we report the first case of sprue-like enteropathy associated with valsartan and irbesartan in Korea.
Journal Title: Journal of Neurogastroenterology and Motility
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!